Tirzepatide was the first dual GLP-1/GIP agonist to demonstrate that adding GIP activity to GLP-1 produces additive metabolic effects in published trials [4]
Limitations: Since this study pulled EHR data from health systemsnot digital health companiesit might not reflect adherence trends in the popular DTC obesity space (e.g., Hims & Hers, Ro, Noom)
The Metabolism Barrier When you drastically cut calories to hit a goal like 15 pounds in 30 days, your body can interpret it as a famine and enter starvation mode. This dramatically lowers your metabolism to conserve energy, making continued progress extremely difficulta phenomenon known as the plateau effect. 2
Researchers studying metabolic dysfunction in adipose tissue have identified NNMT as one of the most consistently upregulated enzymes in obese white fat, making it a high-confidence therapeutic target for metabolic intervention
GLP-1 Medications and Sun Sensitivity: What Patients Need to Know As GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Victoza) reach millions of patients globally, awareness of their UV-related side effects remains low many patients are not informed about photosensitivity risks at time of prescription